Hypertension: PATHWAY to improving the treatment of drug-resistant hypertension

Nat Rev Nephrol. 2015 Nov;11(11):629. doi: 10.1038/nrneph.2015.165. Epub 2015 Oct 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists / therapeutic use*
  • Adrenergic beta-1 Receptor Antagonists / therapeutic use*
  • Bisoprolol / therapeutic use*
  • Doxazosin / therapeutic use*
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Mineralocorticoid Receptor Antagonists / therapeutic use*
  • Spironolactone / therapeutic use*

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic beta-1 Receptor Antagonists
  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Doxazosin
  • Bisoprolol